While everyone is discussing are we in an AI bubble or not, Harvard is teaching how to invest in these irrational times.
Leaders don’t fail from complexity overload. They fail from pretending it’s simple, then engineering systems that move ...
Opinion
AI's promise, biotech's peril: How unequal access to computing power threatens medical breakthroughs
One way leads to a future in which AI-driven breakthroughs remain the exclusive domain of pharmaceutical giants with billion-dollar budgets. The other, to a landscape where breakthroughs regularly ...
New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But delivering those drugs to the ...
Absci (NASDAQ:ABSI) used a presentation at the 44th JPMorgan Healthcare Conference to outline recent platform updates and ...
Sundance: Telling three parallel stories at various points in time, Stanton's film spans 47,000 years in search of a single ...
Q4 2025 Earnings Call January 22, 2026 5:00 PM ESTCompany ParticipantsJohn Pitzer - Corporate Vice President of Corporate ...
Zacks Investment Research on MSNOpinion
Top stock reports for Apple, Walmart & JPMorgan
Tuesday, January 20, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research ...
Cellino, a regenerative medicine company developing autonomous manufacturing systems for personalized cells, today announced the expansion of co-founder Dr. Marinna Madrid's role to Chief Product and ...
Intel Corporation (NASDAQ:INTC) Q4 2025 Earnings Call Transcript January 22, 2026 Intel Corporation beats earnings ...
A new study by researchers in Japan offers new insights into how protocells may have inherited and enriched genetic material before modern biology emerged. By exposing mixed phospholipid vesicles to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results